Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Peter Singleton who wrote (4142)	4/25/1998 12:13:00 AM
From: Steve Fancy	Read Replies (3) of 6136

Peter, you may be right, but at least I'd feel like they understand they're responsibility to shareholders. I don't know if you're suggesting the results of earlier trials are bad news, but if not, certainly couldn't hurt, right. At the moment though, if, and I mean if, Viracept marketshare were to start slipping, what's left to hold the stock up. At this point all we know is that maybe, if we're really lucky, there might be another product on the market in 2001. I think this is where the nervousness in the marketplace is stemming from. Appreciate the comments. regards, sf

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next